help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2005-1487
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Linglart, A.
Right arrow Articles by Bastepe, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Linglart, A.
Right arrow Articles by Bastepe, M.
Endocrinology Vol. 147, No. 5 2253-2262
Copyright © 2006 by The Endocrine Society

Coding GNAS Mutations Leading to Hormone Resistance Impair in Vitro Agonist- and Cholera Toxin-Induced Adenosine Cyclic 3',5'-Monophosphate Formation Mediated by Human XL{alpha}s

Agnès Linglart, Matthew J. Mahon, Mohammad A. Kerachian, David M. Berlach, Geoffrey N. Hendy, Harald Jüppner and Murat Bastepe

Endocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School (A.L., M.J.M., M.B.), Boston, Massachusetts 02114; Pediatric Endocrinology and Institut National de la Santé et de la Recherche Médicale, Unité 561, Saint Vincent de Paul Hospital (A.L.), Paris, France; Departments of Medicine, Physiology, and Human Genetics, McGill University (M.A.K., D.M.B., G.N.H.), and Calcium Research Laboratory, and Hormones and Cancer Research Unit, Royal Victoria Hospital (M.A.K., D.M.B., G.N.H.), Montréal, Québec, Canada; and Pediatric Nephrology Unit, MassGeneral Hospital for Children and Harvard Medical School (H.J.), Boston, Massachusetts 02114

Address all correspondence and requests for reprints to: Dr. Murat Bastepe, Endocrine Unit, Massachusetts General Hospital, 50 Blossom Street, Thier 501, Boston, Massachusetts 02114. E-mail: bastepe{at}helix.mgh.harvard.edu.

Most loss of function mutations of GNAS identified in different forms of pseudohypoparathyroidism disrupt not only the stimulatory G protein {alpha}-subunit (Gs{alpha}), but also its paternally expressed variant, XL{alpha}s. However, the possibility that XL{alpha}s deficiency contributes to disease pathogenesis has remained unexplored. We therefore examined the signaling property of human XL{alpha}s and the effects of one novel (XL{alpha}sH704P or Gs{alpha}H362P) and two previously described (XL{alpha}sDelI724 and XL{alpha}sY733X or Gs{alpha}DelI382 and Gs{alpha}Y391X, respectively) GNAS mutations on either XL{alpha}s or Gs{alpha} activity. Confocal immunofluorescence microscopy detected human XL{alpha}s immunoreactivity at the plasma membrane of transduced mouse embryonic fibroblasts null for endogenous Gs{alpha} and XL{alpha}s (GnasE2–/E2 cells). Cholera toxin- and isoproterenol-induced cAMP accumulation in GnasE2–/E2 cells transiently expressing wild-type human XL{alpha}s was similar to that in cells transiently expressing wild-type Gs{alpha}. Human XL{alpha}s, like Gs{alpha}, mediated PTH-induced cAMP accumulation in GnasE2–/E2 cells coexpressing PTH receptor type 1 and either of these proteins. Moreover, overexpression of human XL{alpha}s or Gs{alpha} markedly enhanced the PTH-induced cAMP accumulation in opossum kidney cells that endogenously express PTH receptor type 1. In contrast, each XL{alpha}s mutant failed to mediate isoproterenol- and PTH-induced cAMP accumulation in transduced GnasE2–/E2 cells. XL{alpha}sDelI724 showed a reduced cholera toxin response over the basal level compared with wild-type XL{alpha}s, and XL{alpha}sH704P completely failed to respond to cholera toxin. These findings were comparable to those observed with each corresponding Gs{alpha} mutant transiently expressed in GnasE2–/E2 cells. Thus, mutations that typically inactivate Gs{alpha} also impair XL{alpha}s activity, consistent with a possible role for XL{alpha}s deficiency in diseases caused by paternal GNAS mutations.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
V. Mariot, S. Maupetit-Mehouas, C. Sinding, M.-L. Kottler, and A. Linglart
A Maternal Epimutation of GNAS Leads to Albright Osteodystrophy and Parathyroid Hormone Resistance
J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 661 - 665.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
A. Plagge, G. Kelsey, and E. L Germain-Lee
Physiological functions of the imprinted Gnas locus and its protein variants G{alpha}s and XL{alpha}s in human and mouse
J. Endocrinol., February 1, 2008; 196(2): 193 - 214.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. Makita, J. Sato, P. Rondard, H. Fukamachi, Y. Yuasa, M. A. Aldred, M. Hashimoto, T. Fujita, and T. Iiri
Human Gs{alpha} mutant causes pseudohypoparathyroidism type Ia/neonatal diarrhea, a potential cell-specific role of the palmitoylation cycle
PNAS, October 30, 2007; 104(44): 17424 - 17429.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
S. Michienzi, N. Cherman, K. Holmbeck, A. Funari, M. T. Collins, P. Bianco, P. G. Robey, and M. Riminucci
GNAS transcripts in skeletal progenitors: evidence for random asymmetric allelic expression of Gs{alpha}
Hum. Mol. Genet., August 15, 2007; 16(16): 1921 - 1930.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society